Jan 2020: GOSSIP Study Clinical Trial gets underway

Updated: Jan 8

After our incredible SAB Foundation grant win, LIQID Medical has begun live trials. Two patients underwent OptiShunt insertion on the 9th December 2019. So far the results are promising and we look forward to improving the speed and technique with which the surgery is carried out. 2020 is off to a great start and we are excited to track the long term outcomes as we progress.


Glaucoma remains a leading cause of blindness worldwide, affecting over 70 million people

Contact

Dr Daemon McClunan, Founder
email: daemon@liqidmedical.com

mobile: +27 (0)84 604 7600

location: Cape Town, South Africa

You Tube icon white edited

© 2017 Copyright reserved. Online Solutions by CassandraGroenewald.com